Diagnostic and Biotech

2016 U.S. Infectious Disease Testing in Hospitals, Labs, Blood Banks and Point-of-Care/POC Locations

  • VPG356077
  • 1060 Pages
  • November 2015
  • Diagnostic and Biotech

Complete report $11,500. DataPack (test volumes, sales forecasts, supplier shares) $7,500.

VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during the nextfive years. The report examines key US market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests performed in hospitals, blood banks, commercial laboratories, physician offices, public health, ER, OR, ICU, cancer clinics, ambulatory care centers, surgery centers, nursing homes, and birth centers; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.



Rationale


This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.



Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the worlds major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.


Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.


Opportunities and Strategic Recommendations


- Emerging opportunities for new instrumentation,

reagents kits, IT and other products with significant market

appeal during the next five years.


- Design criteria for decentralized testing products.


- Alternative market penetration strategies.


- Potential market entry barriers and risks.


Infectious Diseases Analyzed in the Report


AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter,

Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium,

Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea,

Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme disease,

Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps,

Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus,

Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis,

Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.


Market Segmentation Analysis


- Sales and market shares of major suppliers

by individual test.


- Volume and sales forecasts for over 100 infectious disease

assays by individual test and market segment:


Centralized Testing



- Hospitals

- Commercial/Private Laboratories

- Blood Banks

- Public Health Laboratories


POC/Decentralized Testing


- Physician Offices/Group Practices

- Emergency Rooms

- Operating/Recovery Suites

- ICUs/CCUs

- Cancer Clinics

- Ambulatory Care Centers

- Surgery Centers

- Nursing Homes

- Birth Centers


- Test volume estimates by method (molecular, serology/immunodiagnostics,

culture/microscopy).


- Review of the market dynamics, trends,

structure, size, growth and major suppliers.


Current and Emerging Products


- In-depth examination of over 100 major diseases,

including their etiology, current diagnostic tests,

vaccines, drugs and market needs.


- Review of major analyzers used for infectious disease

testing, including their operating

characteristics, features and selling prices.


Technology Review


- Assessment of molecular diagnostic, monoclonal antibody,

immunoassay,and other technologies and their potential

applications for infectious disease testing.


- Global listings of companies developing or

marketing infectious disease diagnostic products

by individual test.


Competitive Assessments


- Strategic assessments of major suppliers and

emerging market entrants, including their sales, product

portfolios, marketing tactics, collaborative

arrangements and new products in R&D.


- The companies analyzed in the report include:


- Abbott

- Affymetrix

- Beckman Coulter/Danaher

- Becton Dickinson

- Biomerieux

- Bio-Rad

- Cepheid

- Diamedix/Erba

- Diasorin

- Eiken Chemical

- Elitech Group

- Enzo Biochem

- Fujirebio

- Grifols

- Hologic/Gen-Probe

- ID Biomedical/GSK

- Kreatech

- Lonza

- Ortho-Clinical Diagnostics

- Qiagen

- Roche

- Scienion

- Sequenom

- SeraCare

- Siemens

- Takara Bio

- ThermoFisher

- Wallac/PE

- Wako


Contains 1,060 pages and 192 tables

Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Malaria Diagnostics Market (Technique and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Malaria is caused by the Plasmodium parasites and is transmitted by the female anopheles mosquito. Diagnosis of malaria includes detection by microscopy and blood tests. According to the WHO, in ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Allergy Diagnostic Market - Opportunities and Forecasts, 2014 - 2020

Allergy is an exaggerated response of immune systems, which causes skin irritation, hay-fever, asthma, anaphylaxis and other symptoms. Therefore, it needs to be diagnosed and treated properly. In order to ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Epigenetics Market - Opportunities and Forecasts, 2015 - 2020

Epigenetics, in the field of genetics, involves study of cellular and physiological trait variations initiated by external or ecological aspects which swipe genes on and off and affect how cells ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Surface Analysis Market - Opportunities and Forecasts, 2014 - 2020

Surface analysis is a technique that provides a medium to correlate performance with thin film conformation. The analysis is used in the discovery of new materials and to enhance the ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Therapies and Diagnostics for Cervical Cancer Market, (Types, Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Cancer has been globally affecting 10million people and it is expected to increase by 2.4% by 2020, reaching to 14 million. Cervical Cancer is a form of cancer that forms ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Pyrogen Testing Market - Opportunities and Forecast, 2015 - 2020

Pyrogen is a thermostable bacterial toxin that induces immunogenic response when administered parenterally. Pyrogen testing is a process that determines the presence of bacterial toxins in vaccines, biotechnological products, and ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>